Abstract
TransfusionVolume 62, Issue 10 p. 2150-2152 LETTER Neutralization profile of SARS-CoV-2 omicron BA.1 variant in high binding titer plasma Lukas Kevlicius, Corresponding Author Lukas Kevlicius [email protected] orcid.org/0000-0003-3536-3701 Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania Correspondence Lukas Kevlicius, Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Santariskiu st. 2, Vilnius 08661, Lithuania. Email: [email protected]Search for more papers by this authorDovile Juozapaite, Dovile Juozapaite Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, LithuaniaSearch for more papers by this authorLina Kryzauskaite, Lina Kryzauskaite Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, LithuaniaSearch for more papers by this authorMigle Montrimaite, Migle Montrimaite Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, LithuaniaSearch for more papers by this authorKarolis Sablauskas, Karolis Sablauskas Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, LithuaniaSearch for more papers by this authorDaniel Naumovas, Daniel Naumovas Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, LithuaniaSearch for more papers by this authorLaimonas Griskevicius, Laimonas Griskevicius Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, LithuaniaSearch for more papers by this author Lukas Kevlicius, Corresponding Author Lukas Kevlicius [email protected] orcid.org/0000-0003-3536-3701 Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania Correspondence Lukas Kevlicius, Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Santariskiu st. 2, Vilnius 08661, Lithuania. Email: [email protected]Search for more papers by this authorDovile Juozapaite, Dovile Juozapaite Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, LithuaniaSearch for more papers by this authorLina Kryzauskaite, Lina Kryzauskaite Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, LithuaniaSearch for more papers by this authorMigle Montrimaite, Migle Montrimaite Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, LithuaniaSearch for more papers by this authorKarolis Sablauskas, Karolis Sablauskas Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, LithuaniaSearch for more papers by this authorDaniel Naumovas, Daniel Naumovas Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, LithuaniaSearch for more papers by this authorLaimonas Griskevicius, Laimonas Griskevicius Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, LithuaniaSearch for more papers by this author First published: 21 August 2022 https://doi.org/10.1111/trf.17079Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume62, Issue10October 2022Pages 2150-2152 RelatedInformation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
